Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Shinokang Biotechnology (also known as Shinokang Pharmaceutical Technology) is a Chinese biotechnology company specializing in the cultivation, processing, and supply of medicinal plant raw materials. As a subsidiary of Yunnan Xikang Biotechnology and part of the Conba Group network, the company operates large-scale agricultural and botanical bases in Yunnan Province. Its primary operations focus on the cultivation of Ginkgo biloba for ginkgo leaf extracts and industrial hemp for cannabinoid extraction. The company provides high-quality botanical raw materials to the pharmaceutical, nutraceutical, and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shinokang Pharmaceutical Technology.